Staburo GmbH
Stefan Bentink is an accomplished professional in the field of bioinformatics, currently serving as the Director of Data Science and Diagnostics at Staburo GmbH since March 2020. Prior experience includes roles as Principal Data Scientist at Definiens from July 2017 to February 2020 and Senior Scientist in Bioinformatics at DKMS from October 2016 to June 2017. Earlier positions were held at Exosome Diagnostics, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, University of Regensburg, Max Planck Institute for Molecular Genetics, and Robert Koch Institute. Stefan Bentink holds a PhD in Bioinformatics from Freie Universität Berlin, a Master's degree from Berlin University of Applied Sciences, and a Diplom in Biology from The Julius Maximilians University of Würzburg.
This person is not in any teams
Staburo GmbH
Staburo GmbH is a data science company, specialized in statistical consulting, programming and bioinformatics for healthcare projects. Our core competencies include Clinical Statistics, Translational Medicine & Biomarkers, Phase I & Pharmacokinetics/-Dynamics, Data Transparency & Disclosure Services, Health Technology Assessment and Bioinformatics. Our customers are international pharmaceutical companies (7 of the top 20), CROs, biotech companies and medical device manufacturers. Our steadily growing team supports our clients efficiently from study design to data analysis and finally the disclosing and posting of trial results. Become part of our constantly growing team and support us in the fulfilment of our core purpose: Excellent data science to improve and save lives. Staburo is kununu top company 2024 (4.7 out of 5 stars).